ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد
نسخه الکترونیک
medimedia.ir

Allergic rhinitis: Clinical manifestations, epidemiology, and diagnosis

Allergic rhinitis: Clinical manifestations, epidemiology, and diagnosis
Literature review current through: May 2024.
This topic last updated: May 20, 2024.

INTRODUCTION AND TERMINOLOGY — Allergic rhinitis, or allergic rhinosinusitis, is characterized by inflammation of the nasal mucosa leading to paroxysms of sneezing, rhinorrhea, and nasal obstruction, often accompanied by itching of the eyes, nose, and palate [1]. Postnasal drip, cough, irritability, and fatigue are other common symptoms [2-4].

Some investigators prefer the term "rhinosinusitis" to the separate terms "rhinitis" and "sinusitis." This is because the nose and sinus mucosa are contiguous, rhinitis and sinusitis frequently occur together, rhinitis commonly leads to sinusitis, and nasal symptoms are common with sinusitis. However, within this topic review, rhinitis and sinusitis are referred to separately given that management issues may differ for each condition, and detailed reviews of acute and chronic sinusitis are presented elsewhere. (See "Acute sinusitis and rhinosinusitis in adults: Clinical manifestations and diagnosis" and "Chronic rhinosinusitis: Clinical manifestations, pathophysiology, and diagnosis" and "Uncomplicated acute sinusitis and rhinosinusitis in adults: Treatment".)

The clinical manifestations, epidemiology, and diagnosis of allergic rhinitis are presented in this topic review. The pathogenesis and treatment of this condition are discussed separately. (See "Pathogenesis of allergic rhinitis (rhinosinusitis)" and "Pharmacotherapy of allergic rhinitis".)

EPIDEMIOLOGY — It is a common condition affecting 10 to 30 percent of children and adults in the United States and other resource-abundant countries [5-10]. It may be less common in some parts of the world, although even resource-limited countries report significant rates [11-17]. There is a higher incidence of allergic rhinitis and allergic diseases in general in urban and industrialized areas when compared with rural areas [18-21].

There has been an increase in the prevalence of allergic rhinitis over the years [22]. The prevalence of asthma, rhinoconjunctivitis, and eczema were systematically evaluated in approximately 1.2 million children in 98 countries in the International Study of Asthma and Allergies in Childhood (ISAAC) [23]. The overall prevalence of rhinoconjunctivitis in children aged 6 to 7 years and 13 to 14 years was 8.5 and 14.6 percent, respectively. A subsequent meta-analysis demonstrated a prevalence of self-reported lifetime allergic rhinitis of 19.93 percent in children [22]. Allergic rhinitis is more common in males in childhood, but this changes to a female predominance in adolescence [24].

Economic burden — Allergic rhinitis is associated with significant morbidity and expense [25-30]:

It accounts for at least 2.5 percent of all clinician visits, 2 million lost school days, 6 million lost work days, and 28 million restricted work days per year.

The average number of annual prescriptions for patients with allergic rhinitis is nearly double that for patients without allergic rhinitis (19 versus 10) [29].

Prescription medications account for almost half of the direct medical costs of rhinitis [31,32].

Economic burden secondary to allergic rhinitis is significant. Costs related to this condition are approximately $3.4 billion in the United States, most of which are associated with medication costs [33]. Medical spending to treat allergic rhinitis almost doubled from 2000 to 2005 (USD $6.1 to $11.2 billion dollars) [34]. In addition to costs directly attributable to allergic rhinitis, the disorder is highly associated with asthma and sinusitis, further expanding its economic impact.

RISK FACTORS — The following are proposed or identified risk factors for allergic rhinitis [17,35-40]:

Personal or family history of atopy (ie, the genetic predisposition to develop allergic diseases) [38,41,42]

Male sex

Birth during the pollen season

Firstborn status

Early use of antibiotics

Maternal smoking exposure in the first year of life

Exposure to indoor allergens, such as dust mite and molds

Serum immunoglobulin E (IgE) >100 international units/mL before age six years

Presence of allergen-specific IgE

Frequent respiratory tract infections or long-lasting infections

Tonsillectomy

Heavy traffic near the home

Consumption of drinks with preservatives/colorants

Living near a weedy area, an air-polluting factory, or a mine

A review of multiple studies reported that the presence of each of these factors was associated with a positive likelihood ratio for the diagnosis that ranged from three to five [43]. (See "Pathogenesis of allergic rhinitis (rhinosinusitis)".)

CLINICAL MANIFESTATIONS

Signs and symptoms — Allergic rhinitis presents with paroxysms of sneezing, rhinorrhea, nasal obstruction, and nasal itching. Postnasal drip, cough, irritability, and fatigue are other common symptoms [2-4]. Some patients experience itching of the palate and inner ear. Those with concomitant allergic conjunctivitis report bilateral itching, tearing, and/or burning of the eyes. (See "Allergic conjunctivitis: Clinical manifestations and diagnosis", section on 'Clinical manifestations'.)

Young children typically do not blow their noses, and instead, they may repeatedly snort, sniff, cough, and clear their throats. Severe nasal congestion can lead to snoring and obstructive sleep apnea. Some scratch their itchy palates with their tongues, producing a clicking sound (palatal click).

Quality of life and cognitive function — Sleep-disturbed breathing is one of the most important sequelae of untreated allergic rhinitis [44,45]. Sleep quality in general is disturbed by allergic rhinitis [40]. Fatigue and generalized malaise are common, although patients rarely report these symptoms directly [46,47]. Allergic rhinitis is associated with a host of cognitive and psychiatric issues in children and adolescents, including attention deficit hyperactivity disorder, lower exam scores during peak pollen seasons [48], poor concentration, impaired athletic performance, and low self-esteem [9,49-51]. In adults, allergic rhinitis is associated with anxiety, depression, reduced academic performance and work productivity (and lower than that of patients with asthma), impaired sexual performance, and lower quality-of-life scores [11,46,52-55].

Patterns of symptoms — Allergic rhinitis may be classified by temporal pattern (intermittent or persistent) and by severity (mild or moderate-severe) (table 1) [56,57]:

Intermittent – Symptoms are present less than four days per week or for less than four weeks.

Persistent – Symptoms are present more than four days per week and for more than four weeks.

Mild – None of the items listed below for "moderate-severe" are present.

Moderate-severe – One or more of the following items is present:

Sleep disturbance

Impairment of school or work performance

Impairment of daily activities, leisure, and/or sport activities

Troublesome symptoms

This classification system was proposed by an international workshop of 34 specialists in respiratory allergy in collaboration with the World Health Organization (WHO) [56]. The WHO had targeted allergic rhinitis because of its impact on asthma and mirrors the consensus asthma guidelines.

Other commonly used terms are "seasonal," which is allergic rhinitis that occurs at a particular time of the year (figure 1), and "perennial," which describes symptoms to allergens that are present year-round [58]. This system of classification is preferred by the US Food and Drug Administration (FDA).

Patients whose symptoms occur episodically are often more aware of the disability caused by allergic rhinitis, whereas patients with chronic symptoms often adapt to significant impairment over time and may not seek medical care until symptoms become severe [50,51,59,60]. Children, in particular, will endure significant disability.

Persistent/perennial symptoms are more common than purely intermittent or seasonal symptoms, although many patients have perennial symptoms with seasonal exacerbations [2,61].

Seasonal allergic rhinitis is usually caused by pollen from trees, grasses, and weeds. Depending upon the geographic area, pollination periods for certain types of plants are well known (figure 1). Colloquial names sometimes correctly identify the triggering pollen (eg, cedar fever), although, in other cases, a plant that is not causing symptoms but is very visible at the same time is implicated by the name (eg, rose fever, which refers to allergic rhinitis caused by grasses that pollinate at the same time that roses bloom or hayfever, which occurs in the fall when hay is being gathered but is caused by weed pollens or from mold growing in the hay). Symptoms of seasonal allergic rhinitis are predictable and reproducible from year to year.

Perennial allergic rhinitis usually reflects allergy to indoor allergens such as dust mites, cockroaches, mold spores, or animal dander, although aeroallergens may cause perennial rhinitis in tropical or subtropical climates. Perennial rhinitis due to outdoor allergens is common in subtropical regions with long pollinating seasons and ubiquitous mold and dust mite allergens. Perennial symptoms are also seen with occupational allergen exposure [62]. (See "Occupational rhinitis".)

It is important to understand that allergic rhinitis, whether seasonal or perennial, may be difficult to distinguish clinically from the nonallergic forms of rhinitis since not all seasonal and perennial symptoms are unique to allergic forms of rhinitis [2,61]. As an example, chronic nonallergic rhinitis can be triggered by changes in weather and temperature and may appear to have a seasonal pattern in some patients. Thus, for an accurate diagnosis of allergic rhinitis, diagnostic testing may be required. (See 'Allergen-specific testing' below and "Chronic nonallergic rhinitis".)

Increasing sensitivity over time — When a patient is continually exposed to an allergen, persistent nasal mucosal inflammation develops. In such patients, symptoms of rhinitis occur on exposure to lower doses of allergen (priming) and to nonspecific irritants (hyperreactivity). Clinically, this results in continued and frequently more severe rhinitis symptoms with exposure to low allergen concentrations. This phenomenon of increasing sensitivity over time probably results from a lowering of the threshold for a clinical response. Sequential allergen challenges in patients with allergic rhinitis result in more symptoms and higher levels of histamine and inflammatory cells in nasal washes [63]. Presumably, the induced inflammation recruits additional inflammatory cells and their products into the process, producing increasing symptoms.

Concomitant with allergen priming, the nose becomes progressively more sensitive to cholinomimetic stimuli, such as methacholine and histamine, as well as irritant stimuli like cold air. Over time, many patients with allergic rhinitis report heightened sensitivity to irritants (eg, tobacco smoke, particulate pollution), volatile substances, and strong scents and perfumes [64].

Physical findings — The following physical findings may be present in patients with active allergic rhinitis [65-68]:

Infraorbital edema and darkening due to subcutaneous venodilation, findings that are sometimes referred to as "allergic shiners."

Accentuated lines or folds below the lower lids (Dennie-Morgan lines), which suggest concomitant allergic conjunctivitis. (See "Allergic conjunctivitis: Clinical manifestations and diagnosis".)

A transverse nasal crease caused by repeated rubbing and pushing the tip of the nose up with the hand (the "allergic salute").

"Allergic facies," which are typically seen in children with early-onset allergic rhinitis, consist of a highly arched palate, open mouth due to mouth breathing, and dental malocclusion (figure 2).

The internal structures of the nose, oropharynx, and ears should be examined:

The nasal mucosa of patients with active allergic rhinitis frequently has a pale bluish hue or pallor along with turbinate edema.

Clear rhinorrhea may be visible anteriorly, or, if the nasal passages are obstructed, rhinorrhea may be visible dripping down the posterior pharynx.

Hyperplastic lymphoid tissue lining the posterior pharynx, which resembles cobblestones (a finding called "cobblestoning").

Tympanic membranes may retract, or serous fluid may accumulate behind tympanic membranes in patients with significant nasal mucosal swelling and eustachian tube dysfunction [69].

Routine laboratory findings — Routine laboratories are usually normal. Neither peripheral blood eosinophil counts nor total serum IgE levels (elevated in only 30 to 40 percent of patients) are sensitive enough to help diagnose allergic rhinitis. (See "The relationship between IgE and allergic disease", section on 'Allergic rhinitis'.)

Natural history — Allergic rhinitis typically requires a few years of allergen exposure to develop. Accordingly, it is uncommon in children under two years of age. If a very young child appears to have persistent nasal symptoms, other disorders should be considered. (See 'Differential diagnosis' below.)

Sensitization to aeroallergens generally precedes the appearance of rhinitis symptoms [17,70]. Sensitization describes the presence of allergen-specific IgE as measured by skin testing or in vitro tests. However, sensitization is not synonymous with allergy, and a person can be sensitized to an allergen without developing symptoms when exposed to that allergen. Only a subset of sensitized individuals demonstrate clinical allergy [71]. The distinction between sensitization and clinical allergy is discussed in more detail elsewhere. (See "The relationship between IgE and allergic disease", section on 'Sensitization'.)

In children, sensitization and then clinical allergy develop first to allergens that are continually present in the environment (eg, dust mites or animal danders) and then to pollens and other seasonal allergens. In a study of approximately 600 children, at least two seasons of pollen exposure were required before most children developed allergic symptoms [72].

After the age of two years, the prevalence of allergic rhinitis steadily increases, demonstrating a bimodal peak in the early school and early adult years. In a prospective study of 2024 children, the prevalence of allergic rhinitis increased from 5 percent at the age of four years to 14 percent at age eight years [17,70]. The prevalence then gradually increases, peaking in early adulthood. The condition is usually persistent throughout adulthood, with some improvement in older age [26,73-78].

Allergic rhinitis uncommonly presents for the first time in older adults, unless there is a significant change in exposures (eg, a new pet or a move to a different climate). Thus, in an older adult with new nasal symptoms, other causes of rhinitis should be considered. A change in response to treatment in older adults may indicate the development of vasomotor or atrophic rhinitis. (See "Atrophic rhinosinusitis".)

ASSOCIATED CONDITIONS — Allergic rhinitis occurs in association with a number of other disorders, including allergic conjunctivitis, acute or chronic sinusitis, asthma, and atopic dermatitis (eczema).

Allergic conjunctivitis – Up to 60 percent of patients with allergic rhinitis have concomitant allergic conjunctivitis [79,80]. Allergic conjunctivitis presents with itching, tearing, conjunctival edema, hyperemia, watery discharge, burning, and photophobia (picture 1). Eyelid edema is also common. Symptoms are usually bilateral. (See "Allergic conjunctivitis: Clinical manifestations and diagnosis".)

Sinusitis – Nasal inflammation associated with allergic rhinitis can also cause obstruction of the sinus ostiomeatal complex, thereby predisposing to bacterial infection of the sinuses. This process accounts for as much as 30 to 80 percent of cases of acute and chronic bacterial sinusitis, respectively. However, purulent sinusitis without concurrent rhinitis is rare given that these tissues are anatomically contiguous [81].

Symptoms of bacterial sinusitis include nasal congestion, purulent rhinorrhea or postnasal drip, facial or dental pain, and cough. Purulent rhinorrhea, purulent postnasal drip, pain in a maxillary tooth, or, in children, persistent cough are the most useful predictors of bacterial sinusitis. However, no single symptom has a high degree of sensitivity or specificity in discriminating bacterial sinusitis from allergic or viral rhinitis. (See "Acute sinusitis and rhinosinusitis in adults: Clinical manifestations and diagnosis" and "Acute bacterial rhinosinusitis in children: Clinical features and diagnosis", section on 'Anatomy'.)

Asthma – Up to 50 percent of patients with asthma have allergic rhinitis. In children, cough and wheeze are the most common symptoms and are often more prominent with exertion (table 2). Adults may report any combination of cough, wheeze, or chest tightness. (See "Epidemiology of asthma" and "Asthma in children younger than 12 years: Initial evaluation and diagnosis" and "Asthma in adolescents and adults: Evaluation and diagnosis".)

Atopic dermatitis (eczema) – In children, atopic dermatitis presents with intensely pruritic erythematous patches with papules and some crusting, usually affecting the face, scalp, extremities, or trunk, with sparing of the diaper areas.

In older individuals with more chronic disease, atopic dermatitis presents with thickened skin, increased skin markings (lichenification), and excoriated and fibrotic papules. The flexural areas (neck, antecubital fossae, and popliteal fossae) are most commonly involved in adults. This disorder is discussed separately. (See "Atopic dermatitis (eczema): Pathogenesis, clinical manifestations, and diagnosis".)

Oral allergy syndrome – Oral allergy syndrome is a form of food allergy that develops in individuals who are sensitized to pollens. Patients report itching and/or mild swelling of the mouth and throat immediately following ingestion of certain uncooked fruits (such as apples, peaches, plums, cherries, and some nuts) or raw vegetables. The symptoms result from contact urticaria in the oropharynx caused by pollen-related proteins in these foods. (See "Clinical manifestations and diagnosis of oral allergy syndrome (pollen-food allergy syndrome)" and "Management and prognosis of oral allergy syndrome (pollen-food allergy syndrome)".)

Other conditions – Allergic rhinitis is strongly associated and probably causally related to eustachian tube dysfunction, causing concomitant serous and acute otitis media [69]. Nasal obstruction due to severe allergic rhinitis can also cause sleep-disordered breathing and anosmia [82,83]. There may be an increased prevalence of migraine headache in patients with allergic rhinitis [84].

DIAGNOSIS — The diagnosis of allergic rhinitis can be made on clinical grounds based upon the presence of characteristic symptoms (ie, paroxysms of sneezing, rhinorrhea, nasal obstruction, nasal itching, postnasal drip, cough, irritability, and fatigue), a suggestive clinical history (including the presence of risk factors), and supportive findings on physical examination [85,86]. Skin prick testing confirms that the patient is sensitized to aeroallergens, although it is not necessary for the initial diagnosis. Serum IgE testing can be used as a reasonable alternative for skin prick testing in situations where patients cannot undergo the latter (eg, severe dermatologic condition) [40,86].

There is insufficient evidence to routinely support other testing [86]. Imaging is not usually performed in the diagnosis of allergic rhinitis unless a concomitant condition such as chronic rhinosinusitis (CRS) is suspected or there is a history of facial trauma or features to suggest anatomic abnormalities (unilateral congestion or obstruction).

If the patient's symptoms prove difficult to manage or the trigger(s) for the symptoms are not apparent, then further evaluation is indicated to demonstrate that the patient is sensitized to aeroallergens and that symptoms occur when expected for the allergens in question. Sensitization can be demonstrated with either allergy skin testing or in vitro tests for allergen-specific IgE. (See 'When to refer' below.)

A positive response to a therapeutic trial of either topical nasal corticosteroids or topical antihistamines does not conclusively establish a diagnosis of allergic rhinitis, because these therapies are also effective in the treatment of nonallergic rhinitis [2,87]. (See "Chronic nonallergic rhinitis", section on 'Management'.)

History — Some forms of allergic rhinitis can be readily diagnosed by history alone, while others may require additional evaluation for accurate diagnosis:

Seasonal allergic rhinitis is often diagnosed by the history alone because it is reproducible from year to year. Seasonal allergic rhinitis caused by tree and grass pollen typically occurs in the spring and summer, and symptoms caused by ragweed pollen exposure occur in the fall, although there are regional variations (figure 1).

Some cases of episodic allergic rhinitis can be diagnosed by history alone if there is an obvious connection between exposure and the onset of symptoms. As an example, a history of episodic exposure to animals or high levels of house dust resulting in acute allergic symptoms may be readily diagnosed as episodic allergic rhinitis.

By comparison, the culprit allergens in perennial/persistent allergic rhinitis may not be readily apparent from the clinical history. Perennial allergic rhinitis usually reflects allergy to indoor allergens like dust mites, cockroaches, or animal dander, although pollens may cause perennial rhinitis in tropical or subtropical climates.

A British study of 143 adult subjects evaluated the ability of specific questions to identify patients in whom subsequent skin testing for common aeroallergens was likely to be negative. Among patients who answered "no" to all four of the below questions, 88 percent had negative results on skin prick testing to house dust mite, mixed grass pollen, and cat and dog aeroallergens [88].

Do you have or have you ever had hayfever?

Do your parents or any of your siblings have or have they ever had hayfever?

Do your allergy symptoms vary when you go from place to place (eg, on holiday)?

Is there a specific trigger that always sets off your allergy symptoms?

For populations living in similar temperate regions of the world, this may be a useful tool for identifying patients who are less likely to benefit from an allergic diagnostic evaluation, although it may not apply to all ages and populations (eg, geographic, climatic, and phenotypic/genotypic heterogeneity) and should be validated in larger numbers of people.

Physical examination — The nose, oropharynx, tympanic membranes, and eyes should be examined as each of these structures may show findings of allergic rhinitis or associated disorders. (See 'Physical findings' above.)

The internal structures of the nose and the nasal mucosa can be visualized using a standard office otoscope with a disposable tip. Stabilizing the tip against the patient's upper nares prevents painful prodding of the mucosa, which is normally exquisitely sensitive to touch.

In patients older than five years of age, flexible fiberoptic rhinoscopy is helpful but not essential for diagnosis. If pursued, it should be performed by clinicians specifically trained in the technique. This technique is described elsewhere. (See "Chronic rhinosinusitis: Clinical manifestations, pathophysiology, and diagnosis", section on 'Rhinoscopy and endoscopy'.)

Allergen-specific testing — It is not necessary to perform testing for allergen-specific IgE either with blood tests or skin testing before making the presumptive diagnosis of allergic rhinitis and initiating treatment. Primary care clinicians treat the majority of patients with allergic rhinitis and often initiate therapy empirically, identifying possible triggers only through the clinical history. This approach is adequate for many patients.

Despite the above, the use of diagnostic testing to identify culprit allergens has been associated with improved patient outcomes [89]. Identifying the allergens that are important to an individual facilitates avoidance of the allergen and identifies candidates for allergen immunotherapy, which can eventually reduce reliance on chronic medications.

Skin testing — Immediate hypersensitivity skin testing (prick skin tests) is a quick and cost-effective way to identify the presence of allergen-specific IgE [90-92]. These tests are usually performed by allergy specialists because, although generally considered quite safe, rare systemic allergic reactions are possible in response to the testing itself. In addition, an allergist can properly pair the skin prick test results to the clinical history and better interpret indeterminate pick test responses (eg, in the setting of concomitant dermographism). In sensitive patients, testing with selected diagnostic solutions of tree, grass, or weed pollen, mold, house dust mite, and/or animal allergens results in a wheal-and-flare reaction at the skin test site within 15 to 20 minutes [92]. Positive prick skin tests correlate more closely with symptoms than intradermal tests. (See "Overview of skin testing for IgE-mediated allergic disease".)

Skin testing is particularly useful among patients with:

An unclear diagnosis based upon the history and physical examination

Poorly controlled symptoms, such as persistent nasal symptoms and/or an inadequate clinical response to nasal corticosteroids

Coexisting persistent asthma and/or recurrent sinusitis/otitis

A high pretest probability of allergic rhinitis and negative in vitro test results to suspected culprit allergens (because the sensitivity of skin testing is usually superior to that of in vitro testing)

A patient's expressed desire to try to avoid the allergen rather than take medications to control symptoms

Serum tests for allergy — IgE immunoassays provide similar information as that obtained with allergen skin tests, although they are more expensive and less sensitive for the diagnosis of allergy to inhalant allergens compared with skin tests. However, in vitro testing can be useful when skin testing is not available or cannot be performed because patients have extensive skin disease, cannot discontinue antihistamines or other interfering medications, are dermatographic, or have other issues that complicate skin testing [40,86,91,93-95]. The advantages of in vitro allergy testing as well as the sensitivity and specificity of IgE immunoassays are reviewed elsewhere. (See "Overview of in vitro allergy tests".)

Commercially available test panels intended for use by generalists typically detect IgE antibodies to common seasonal and perennial inhalant allergens [90]. However, this approach can be costly if excessive numbers of immunoassays are included or if the allergens selected are not relevant to the geographic area in question. A logical approach would involve consulting an allergy expert in the area initially to identify a small number of important allergens for the area (eg, a few prominent pollens, animal danders, molds for dry environments, and dust mites for humid environments) [96].

Suggestive history with negative testing — Occasionally, a patient presents with a history and physical findings suggestive of allergic rhinitis, but skin testing and in vitro testing are negative. Most commonly, such patients have chronic nonallergic rhinitis, which has subtly different historical features and physical findings. (See 'Differential diagnosis' below.)

Another possibility is that the patient is producing allergen-specific IgE locally in the nasal tissues, but it is not reflected in the systemic circulation or skin. However, nasal allergen provocation tests are positive. This condition is sometimes referred to as "local allergic rhinitis," which may have either intermittent or persistent symptoms, and it is an area of increasing research interest [97]. Local allergic rhinitis is discussed separately. (See "Chronic nonallergic rhinitis", section on 'Evidence for a localized allergic response'.)

Fortunately, patients with either of these disorders may be managed similarly to those with allergic rhinitis. (See "Pharmacotherapy of allergic rhinitis", section on 'Summary and recommendations'.)

Uncommonly used tests — Nasal cytology and direct inhalational challenge with allergen are techniques that are largely limited to research settings.

Nasal cytology — Nasal cytology is performed by some investigators to help differentiate rhinitis due to allergy from that due to infection, although it is relatively nonspecific and insensitive. Nasal secretions may be obtained with a cotton swab or by asking the patient to blow the nose onto waxed paper or cellophane. Wright stain of nasal secretions usually but not always reveals a predominance of eosinophils in cases of allergic rhinitis. By comparison, the presence of neutrophils suggests an infectious process.

Nasal eosinophilia may also be seen in other conditions including:

Asthma without symptoms of nasal allergy

Nasal polyposis, with or without asthma and aspirin sensitivity (see "Aspirin-exacerbated respiratory disease")

Nonallergic rhinitis with eosinophilia syndrome (NARES), a syndrome of marked nasal eosinophilia and a propensity for nasal polyps but with negative allergic histories, negative skin tests, and no aspirin sensitivity (see 'Differential diagnosis' below)

Some also utilize nasal cytology to assess the response to antiinflammatory medications, thereby providing further support for a particular diagnosis. Eosinophilia, for example, should decrease with therapy in patients with allergic rhinitis.

Allergen challenge — Although nasal allergen challenge can definitively establish the diagnosis, it is clinically impractical and rarely performed outside of research settings. Nasal challenge procedures are discussed elsewhere. (See "Chronic nonallergic rhinitis", section on 'Evidence for a localized allergic response' and "Occupational rhinitis".)

Unproven diagnostic tests — There are several unproven or inappropriate diagnostic testing assays that are being offered by various types of providers with increasing frequency. These include cytotoxic testing, provocation neutralization testing, and specific or nonspecific immunoglobulin G (IgG) determinations [98]. The results of these methods are not useful for diagnosis or management.

WHEN TO REFER — Patients whose symptoms are severe or refractory to therapy should be referred to an allergy specialist for a more definitive evaluation [2,99]. Referral to an allergy or pulmonary specialist is also useful for patients with concomitant allergic rhinitis and asthma, and an otolaryngologist may be helpful in managing patients with recurrent episodes of sinusitis or otitis media.

DIFFERENTIAL DIAGNOSIS — Various other disorders can mimic allergic rhinitis or coexist with it in older children and adults.

Children under two years of age — Because allergic sensitization takes a few years to develop, other disorders should be considered in very young children who have persistent rhinitis symptoms. (See 'Natural history' above.)

These include adenoidal hypertrophy, acute or chronic sinusitis, congenital abnormalities (choanal atresia), foreign bodies, and nasal polyps. (See "The pediatric physical examination: HEENT", section on 'Nose'.)

Older children and adults — Rhinitis can result from either inflammatory or noninflammatory causes [100].

Acute infectious rhinitis – Symptoms of the common cold vary from patient to patient, with rhinitis and nasal congestion being the most common. Nasal obstruction, rhinorrhea, and sneezing are usually present early in the course of the cold, although a sore or "scratchy" throat is frequently the most bothersome symptom on the first day of illness. The sore throat is usually short lived, and nasal symptoms predominate by the second and third day. Cough typically becomes troublesome on the fourth or fifth day of illness, by which time the nasal symptoms are less severe. (See "The common cold in adults: Diagnosis and clinical features".)

Acute bacterial sinusitis develops in 0.5 to 2.5 percent of adult patients after viral upper respiratory tract infection. Viral sinusitis occurs much more frequently. The clinical presentation of the patient is of limited utility in distinguishing cases of pure viral rhinosinusitis from those with secondary bacterial infection. There appear to be no signs and symptoms of acute respiratory illness that are both sensitive and specific in making this distinction. (See "Acute sinusitis and rhinosinusitis in adults: Clinical manifestations and diagnosis".)

The remaining disorders discussed below result from chronic processes.

Chronic nonallergic rhinitis – Approximately 50 percent of patients with chronic rhinitis have a component of nonallergic rhinitis [101]. Chronic nonallergic rhinitis is characterized by perennial symptoms and mild or absent nasal itching and sneezing. Patients with this disorder complain of chronic nasal congestion and/or rhinorrhea that is intensified by rapid changes in temperature and relative humidity, odors, or alcohol. They have little nasal itching or sneezing. However, headaches, anosmia, and sinusitis are common. A family history of allergy or allergic symptom triggers is uncommon. Negative skin tests to inhalant allergens are essentially diagnostic for a nonallergic rhinitis syndrome. Syndromes of nonallergic rhinitis include vasomotor rhinitis, gustatory rhinitis, and nonallergic rhinitis with nasal eosinophilia syndrome. These are reviewed in more detail separately. (See "Chronic nonallergic rhinitis".)

Chronic rhinosinusitis – Chronic rhinosinusitis (CRS) is defined as an inflammatory condition involving the paranasal sinuses and linings of the nasal passages that lasts 12 weeks or longer despite attempts at medical management. CRS can coexist with allergic rhinitis. The diagnosis of CRS requires any two of the following symptoms, present for at least 12 weeks:

Anterior and/or posterior mucopurulent drainage

Nasal obstruction

Facial pain, pressure, and/or fullness

Decreased sense of smell

Concomitant CRS should be considered when a patient with allergic rhinitis also has the above mentioned symptoms and fails to improve with treatment for allergic rhinitis. The diagnosis of CRS is discussed in greater detail elsewhere. (See "Chronic rhinosinusitis: Clinical manifestations, pathophysiology, and diagnosis".)

Rhinitis medicamentosa – Rhinitis medicamentosa is a complication of vasoconstrictor nasal sprays (which may develop with as little as five days of use) or intranasal cocaine abuse. Chronic nasal obstruction and nasal inflammation develop and are manifested as beefy red nasal membranes on physical examination. Diagnosis depends almost entirely on the appropriate history, characteristic physical examination findings, and positive response to treatment with topical nasal corticosteroids, which is usually required to withdraw successfully from the culprit medication [102-104]. (See "Chronic nonallergic rhinitis", section on 'Management of rhinitis medicamentosa'.)

Rhinitis due to systemic medications – A variety of systemic medications can induce nasal symptoms. This is in contrast to rhinitis medicamentosa, which is a specific syndrome that results from the intranasal application of certain drugs.

Classes of medications that can cause nasal symptoms include birth control pills, antihypertensive drugs (alpha-adrenergic blockers, beta-adrenergic blockers, angiotensin-converting enzyme [ACE] inhibitors), erectile dysfunction drugs, and nonsteroidal antiinflammatory drugs (NSAIDs). Psychiatric medications that have been implicated include chlorpromazine, thioridazine, perphenazine, chlordiazepoxide, amitriptyline, and alprazolam. Lastly, the immunosuppressants cyclosporine and mycophenolic acid can cause nasal symptoms [105]. Rhinitis symptoms caused by these medications generally subside within a few weeks of discontinuation.

Atrophic rhinitis – Atrophic rhinitis is a syndrome of progressive atrophy of the nasal mucosa usually seen in older adults. Such individuals report chronic nasal congestion and perceive a persistent bad odor. This condition is associated with mucosal colonization with Klebsiella ozaenae. A variant occurs in patients who have had multiple sinus surgeries resulting in loss of normal mucociliary function. This is discussed separately. (See "Atrophic rhinosinusitis".)

Rhinitis associated with hormonal changes – Rhinitis of pregnancy and rhinitis of hypothyroidism reflect nasal obstruction that occurs on a hormonal basis. In these settings, the diagnosis is clinical and is supported by negative skin tests or improved symptoms upon resolution or treatment of the causative condition. (See "Clinical manifestations of hypothyroidism" and "Maternal adaptations to pregnancy: Dyspnea and other physiologic respiratory changes", section on 'Physiologic pulmonary changes in pregnancy'.)

Unilateral rhinitis or nasal polyps – Unilateral rhinitis or nasal polyps are uncommon in uncomplicated allergic rhinitis. Unilateral rhinitis suggests the possibility of nasal obstruction by a foreign body, tumor, or polyp, and the presence of nasal polyps suggests nonallergic rhinitis with eosinophilia syndrome (NARES), chronic bacterial sinusitis, allergic fungal sinusitis, aspirin hypersensitivity, cystic fibrosis, or primary ciliary dyskinesia (immotile cilia syndrome). Fiberoptic rhinoscopy may be helpful in this setting. Increasing evidence also suggests that the histology of those with rhinitis with or without nasal polyps are different, with eosinophils or neutrophils predominating in those with or without polyps, respectively [100]. However, allergic rhinosinusitis and NARES are both conditions characterized by nasal eosinophilia, but most patients with these conditions lack nasal polyps. (See "Chronic rhinosinusitis: Clinical manifestations, pathophysiology, and diagnosis" and "Fungal rhinosinusitis" and "Epidemiology and clinical manifestations of invasive aspergillosis" and "Cystic fibrosis: Clinical manifestations and diagnosis".)

Rhinitis with immunologic disorders – A number of systemic autoimmune disorders present with nasal symptoms or can affect nasal mucosa. These include granulomatosis with polyangiitis and relapsing polychondritis:

The most common presenting symptoms of granulomatosis with polyangiitis include persistent rhinorrhea, purulent/bloody nasal discharge, oral and/or nasal ulcers, polyarthralgias, myalgias, or sinus pain.

With relapsing polychondritis, symptoms of stuffiness, crusting, rhinorrhea, and, on occasion, epistaxis may accompany nasal cartilage inflammation, which can also compromise olfaction. Cartilage destruction associated with sustained or recurrent episodes of inflammation can result in a characteristic saddle-nose deformity.

Such disorders may therefore present with nasal symptoms, without evidence of systemic disease. These disorders are diagnosed based upon the combination of characteristic histologic and clinical findings. (See "Granulomatosis with polyangiitis and microscopic polyangiitis: Clinical manifestations and diagnosis" and "Clinical manifestations of relapsing polychondritis".)

SOCIETY GUIDELINE LINKS — Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See "Society guideline links: Rhinitis".)

INFORMATION FOR PATIENTS — UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5th to 6th grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10th to 12th grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.

Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)

Basics topics (see "Patient education: Environmental allergies in adults (The Basics)" and "Patient education: Environmental allergies in children (The Basics)" and "Patient education: Allergy skin testing (The Basics)")

Beyond the Basics topic (see "Patient education: Allergic rhinitis (Beyond the Basics)")

SUMMARY

Clinical manifestations – Allergic rhinitis is characterized by paroxysms of sneezing, rhinorrhea, nasal obstruction, postnasal drainage, and itching of the eyes, nose, and palate. More insidious effects of the disorder include fatigue, irritability, reduced performance at school and work, and depression. (See 'Introduction and terminology' above and 'Clinical manifestations' above.)

Epidemiology and economic impact – Allergic rhinitis affects 10 to 30 percent of children and adults in the United States. The prevalence is increasing in industrialized countries worldwide, particularly in urban areas. Although frequently underdiagnosed and undertreated, allergic rhinitis imposes a significant economic burden as a result of reduced school performance and work productivity, clinician visits, expense of over-the-counter and prescription medications, and cost of treating related conditions, such as sinusitis and asthma. (See 'Epidemiology' above and 'Associated conditions' above.)

Subtypes – Allergic rhinitis may be classified by temporal pattern (intermittent or persistent) and by severity (mild or moderate-severe) (table 1). (See 'Patterns of symptoms' above.)

Diagnosis – The diagnosis of allergic rhinitis is made clinically based on a suggestive history (including presence of risk factors), characteristic symptoms and signs on physical examination, and (if indicated) the confirmed presence of allergen-specific immunoglobulin E (IgE). Symptoms should also be reproducible (by history) upon exposure to allergens to which the patient is sensitized. (See 'Diagnosis' above.)

Allergen-specific testing – Identification of the specific allergens to which the patient is sensitive is not necessary for successful treatment in many cases. However, patients whose symptoms are severe or refractory to therapy should be referred to an allergy specialist for a more definitive evaluation. Properly performed skin testing is the best method for determining allergic sensitization. (See 'Allergen-specific testing' above.)

Differential diagnosis – The differential diagnosis of allergic rhinitis includes acute and chronic rhinosinusitis (CRS), chronic nonallergic rhinitis, rhinitis medicamentosa, atrophic rhinitis, and rhinitis due to systemic medications. (See 'Differential diagnosis' above.)

ACKNOWLEDGMENTS — The UpToDate editorial staff acknowledges Richard D deShazo, MD and Stephen F Kemp, MD, who contributed to earlier versions of this topic review.

  1. Iordache A, Balica NC, Horhat ID, et al. A Review Regarding the Connections between Allergic Rhinitis and Asthma - Epidemiology, Diagnosis and Treatment. Curr Health Sci J 2023; 49:5.
  2. Dykewicz MS, Wallace DV, Amrol DJ, et al. Rhinitis 2020: A practice parameter update. J Allergy Clin Immunol 2020; 146:721.
  3. Ng ML, Warlow RS, Chrishanthan N, et al. Preliminary criteria for the definition of allergic rhinitis: a systematic evaluation of clinical parameters in a disease cohort (I). Clin Exp Allergy 2000; 30:1314.
  4. Ng ML, Warlow RS, Chrishanthan N, et al. Preliminary criteria for the definition of allergic rhinitis: a systematic evaluation of clinical parameters in a disease cohort (II). Clin Exp Allergy 2000; 30:1417.
  5. US Department of Health and Human Services. Agency for Healthcare Research and Quality. Management of allergic and nonallergic rhinitis. May 2002. AHQR publication 02:E023, Boston, MA. Summary, Evidence Report/Technology Assessment: No 54. http://www.ahrq.gov/clinic/epcsums/rhinsum.htm (Accessed on August 03, 2007).
  6. Settipane RA. Demographics and epidemiology of allergic and nonallergic rhinitis. Allergy Asthma Proc 2001; 22:185.
  7. Singh K, Axelrod S, Bielory L. The epidemiology of ocular and nasal allergy in the United States, 1988-1994. J Allergy Clin Immunol 2010; 126:778.
  8. Wu WF, Wan KS, Wang SJ, et al. Prevalence, severity, and time trends of allergic conditions in 6-to-7-year-old schoolchildren in Taipei. J Investig Allergol Clin Immunol 2011; 21:556.
  9. Meltzer EO, Blaiss MS, Derebery MJ, et al. Burden of allergic rhinitis: results from the Pediatric Allergies in America survey. J Allergy Clin Immunol 2009; 124:S43.
  10. Abdulrahman H, Hadi U, Tarraf H, et al. Nasal allergies in the Middle Eastern population: results from the "Allergies in Middle East Survey". Am J Rhinol Allergy 2012; 26 Suppl 1:S3.
  11. Romano-Zelekha O, Graif Y, Garty BZ, et al. Trends in the prevalence of asthma symptoms and allergic diseases in Israeli adolescents: results from a national survey 2003 and comparison with 1997. J Asthma 2007; 44:365.
  12. Lima RG, Pastorino AC, Casagrande RR, et al. Prevalence of asthma, rhinitis and eczema in 6 - 7 years old students from the western districts of São Paulo City, using the standardized questionnaire of the "International Study of Asthma and Allergies in Childhood" (ISAAC)-phase IIIB. Clinics (Sao Paulo) 2007; 62:225.
  13. Kong WJ, Chen JJ, Zheng ZY, et al. Prevalence of allergic rhinitis in 3-6-year-old children in Wuhan of China. Clin Exp Allergy 2009; 39:869.
  14. Abong JM, Kwong SL, Alava HD, et al. Prevalence of allergic rhinitis in Filipino adults based on the National Nutrition and Health Survey 2008. Asia Pac Allergy 2012; 2:129.
  15. Zar HJ, Ehrlich RI, Workman L, Weinberg EG. The changing prevalence of asthma, allergic rhinitis and atopic eczema in African adolescents from 1995 to 2002. Pediatr Allergy Immunol 2007; 18:560.
  16. Kabir ML, Rahman F, Hassan MQ, et al. Asthma, atopic eczema and allergic rhino-conjunctivitis in school children. Mymensingh Med J 2005; 14:41.
  17. Wise SK, Damask C, Roland LT, et al. International consensus statement on allergy and rhinology: Allergic rhinitis - 2023. Int Forum Allergy Rhinol 2023; 13:293.
  18. Mazur M, Czarnobilska M, Dyga W, Czarnobilska E. Trends in the Epidemiology of Allergic Diseases of the Airways in Children Growing Up in an Urban Agglomeration. J Clin Med 2022; 11.
  19. Elholm G, Linneberg A, Husemoen LL, et al. The Danish urban-rural gradient of allergic sensitization and disease in adults. Clin Exp Allergy 2016; 46:103.
  20. Li CW, Chen DH DH, Zhong JT, et al. Epidemiological characterization and risk factors of allergic rhinitis in the general population in Guangzhou City in china. PLoS One 2014; 9:e114950.
  21. Morgan BW, Siddharthan T, Grigsby MR, et al. Asthma and Allergic Disorders in Uganda: A Population-Based Study Across Urban and Rural Settings. J Allergy Clin Immunol Pract 2018; 6:1580.
  22. Licari A, Magri P, De Silvestri A, et al. Epidemiology of Allergic Rhinitis in Children: A Systematic Review and Meta-Analysis. J Allergy Clin Immunol Pract 2023; 11:2547.
  23. Mallol J, Crane J, von Mutius E, et al. The International Study of Asthma and Allergies in Childhood (ISAAC) Phase Three: a global synthesis. Allergol Immunopathol (Madr) 2013; 41:73.
  24. Pinart M, Keller T, Reich A, et al. Sex-Related Allergic Rhinitis Prevalence Switch from Childhood to Adulthood: A Systematic Review and Meta-Analysis. Int Arch Allergy Immunol 2017; 172:224.
  25. Vandenplas O, Vinnikov D, Blanc PD, et al. Impact of Rhinitis on Work Productivity: A Systematic Review. J Allergy Clin Immunol Pract 2018; 6:1274.
  26. D'Alonzo GE Jr. Scope and impact of allergic rhinitis. J Am Osteopath Assoc 2002; 102:S2.
  27. Woods L, Craig TJ. The importance of rhinitis on sleep, daytime somnolence, productivity and fatigue. Curr Opin Pulm Med 2006; 12:390.
  28. Schatz M, Zeiger RS, Chen W, et al. The burden of rhinitis in a managed care organization. Ann Allergy Asthma Immunol 2008; 101:240.
  29. Bhattacharyya N. Incremental healthcare utilization and expenditures for allergic rhinitis in the United States. Laryngoscope 2011; 121:1830.
  30. Bender BG. Cognitive effects of allergic rhinitis and its treatment. Immunol Allergy Clin North Am 2005; 25:301.
  31. Blaiss MS. Allergic rhinitis: Direct and indirect costs. Allergy Asthma Proc 2010; 31:375.
  32. Meltzer EO. The role of nasal corticosteroids in the treatment of rhinitis. Immunol Allergy Clin North Am 2011; 31:545.
  33. Meltzer EO, Bukstein DA. The economic impact of allergic rhinitis and current guidelines for treatment. Ann Allergy Asthma Immunol 2011; 106:S12.
  34. Soni A. Allergic rhinitis: trends in use and expenditures, 2000 to 2005. Statistical Brief #204, Agency for Healthcare Research and Quality; Bethesda, MD 2008.
  35. Matheson MC, Dharmage SC, Abramson MJ, et al. Early-life risk factors and incidence of rhinitis: results from the European Community Respiratory Health Study--an international population-based cohort study. J Allergy Clin Immunol 2011; 128:816.
  36. Frew AJ. Advances in environmental and occupational diseases 2003. J Allergy Clin Immunol 2004; 113:1161.
  37. Saulyte J, Regueira C, Montes-Martínez A, et al. Active or passive exposure to tobacco smoking and allergic rhinitis, allergic dermatitis, and food allergy in adults and children: a systematic review and meta-analysis. PLoS Med 2014; 11:e1001611.
  38. Rönmark E, Bunne J, Bjerg A, et al. Prevalence and risk factors for allergic sensitization: 3 cross-sectional studies among schoolchildren from 1996 to 2017. J Allergy Clin Immunol Glob 2023; 2:100150.
  39. Sultész M, Horváth A, Molnár D, et al. Prevalence of allergic rhinitis, related comorbidities and risk factors in schoolchildren. Allergy Asthma Clin Immunol 2020; 16:98.
  40. Wise SK, Damask C, Greenhawt M, et al. A Synopsis of Guidance for Allergic Rhinitis Diagnosis and Management From ICAR 2023. J Allergy Clin Immunol Pract 2023; 11:773.
  41. Alm B, Goksör E, Thengilsdottir H, et al. Early protective and risk factors for allergic rhinitis at age 4½ yr. Pediatr Allergy Immunol 2011; 22:398.
  42. Masuda S, Nagao M, Usui S, et al. Development of allergic rhinitis in early life: A prospective cohort study in high-risk infants. Pediatr Allergy Immunol 2022; 33:e13733.
  43. Gendo K, Larson EB. Evidence-based diagnostic strategies for evaluating suspected allergic rhinitis. Ann Intern Med 2004; 140:278.
  44. Georgalas C. The role of the nose in snoring and obstructive sleep apnoea: an update. Eur Arch Otorhinolaryngol 2011; 268:1365.
  45. Koinis-Mitchell D, Craig T, Esteban CA, Klein RB. Sleep and allergic disease: a summary of the literature and future directions for research. J Allergy Clin Immunol 2012; 130:1275.
  46. Meltzer EO, Nathan R, Derebery J, et al. Sleep, quality of life, and productivity impact of nasal symptoms in the United States: findings from the Burden of Rhinitis in America survey. Allergy Asthma Proc 2009; 30:244.
  47. Blaiss MS. Pediatric allergic rhinitis: physical and mental complications. Allergy Asthma Proc 2008; 29:1.
  48. Blaiss MS, Hammerby E, Robinson S, et al. The burden of allergic rhinitis and allergic rhinoconjunctivitis on adolescents: A literature review. Ann Allergy Asthma Immunol 2018; 121:43.
  49. Brawley A, Silverman B, Kearney S, et al. Allergic rhinitis in children with attention-deficit/hyperactivity disorder. Ann Allergy Asthma Immunol 2004; 92:663.
  50. Marshall PS, O'Hara C, Steinberg P. Effects of seasonal allergic rhinitis on selected cognitive abilities. Ann Allergy Asthma Immunol 2000; 84:403.
  51. Walker S, Khan-Wasti S, Fletcher M, et al. Seasonal allergic rhinitis is associated with a detrimental effect on examination performance in United Kingdom teenagers: case-control study. J Allergy Clin Immunol 2007; 120:381.
  52. Léger D, Annesi-Maesano I, Carat F, et al. Allergic rhinitis and its consequences on quality of sleep: An unexplored area. Arch Intern Med 2006; 166:1744.
  53. Postolache TT, Lapidus M, Sander ER, et al. Changes in allergy symptoms and depression scores are positively correlated in patients with recurrent mood disorders exposed to seasonal peaks in aeroallergens. ScientificWorldJournal 2007; 7:1968.
  54. Benninger MS, Benninger RM. The impact of allergic rhinitis on sexual activity, sleep, and fatigue. Allergy Asthma Proc 2009; 30:358.
  55. Meltzer EO, Blaiss MS, Naclerio RM, et al. Burden of allergic rhinitis: allergies in America, Latin America, and Asia-Pacific adult surveys. Allergy Asthma Proc 2012; 33 Suppl 1:S113.
  56. Bousquet J, Van Cauwenberge P, Khaltaev N, et al. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001; 108:S147.
  57. Bousquet J, Khaltaev N, Cruz AA, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 2008; 63 Suppl 86:8.
  58. Scadding GK. Recent advances in the treatment of rhinitis and rhinosinusitis. Intern Congr Series 2003; 1254:347.
  59. Kremer B, den Hartog HM, Jolles J. Relationship between allergic rhinitis, disturbed cognitive functions and psychological well-being. Clin Exp Allergy 2002; 32:1310.
  60. Fineman SM. The burden of allergic rhinitis: beyond dollars and cents. Ann Allergy Asthma Immunol 2002; 88:2.
  61. Settipane RA, Lieberman P. Update on nonallergic rhinitis. Ann Allergy Asthma Immunol 2001; 86:494.
  62. Siracusa A, Desrosiers M, Marabini A. Epidemiology of occupational rhinitis: prevalence, aetiology and determinants. Clin Exp Allergy 2000; 30:1519.
  63. Wachs M, Proud D, Lichtenstein LM, et al. Observations on the pathogenesis of nasal priming. J Allergy Clin Immunol 1989; 84:492.
  64. Sarin S, Undem B, Sanico A, Togias A. The role of the nervous system in rhinitis. J Allergy Clin Immunol 2006; 118:999.
  65. Howarth PH. Allergic and nonallergic rhinitis. In: Middleton's allergy: Principles and practice, 6th ed, Adkinson NF, Yunginger JW, Busse WW, et al (Eds), Mosby, St. Louis 2003. p.1391.
  66. Greiwe JC, Bernstein JA. Allergic and Mixed Rhinitis: Diagnosis and Natural Evolution. J Clin Med 2019; 8.
  67. Small P, Keith PK, Kim H. Allergic rhinitis. Allergy Asthma Clin Immunol 2018; 14:51.
  68. Goniotakis I, Perikleous E, Fouzas S, et al. A Clinical Approach of Allergic Rhinitis in Children. Children (Basel) 2023; 10.
  69. Hurst DS. The role of allergy in otitis media with effusion. Otolaryngol Clin North Am 2011; 44:637.
  70. Westman M, Stjärne P, Asarnoj A, et al. Natural course and comorbidities of allergic and nonallergic rhinitis in children. J Allergy Clin Immunol 2012; 129:403.
  71. Blomme K, Tomassen P, Lapeere H, et al. Prevalence of allergic sensitization versus allergic rhinitis symptoms in an unselected population. Int Arch Allergy Immunol 2013; 160:200.
  72. Kulig M, Klettke U, Wahn V, et al. Development of seasonal allergic rhinitis during the first 7 years of life. J Allergy Clin Immunol 2000; 106:832.
  73. Dottorini ML, Bruni B, Peccini F, et al. Skin prick-test reactivity to aeroallergens and allergic symptoms in an urban population of central Italy: a longitudinal study. Clin Exp Allergy 2007; 37:188.
  74. Kong W, Chen J, Wang Y, et al. A population-based 5-year follow-up of allergic rhinitis in Chinese children. Am J Rhinol Allergy 2012; 26:315.
  75. Kurukulaaratchy RJ, Karmaus W, Arshad SH. Sex and atopy influences on the natural history of rhinitis. Curr Opin Allergy Clin Immunol 2012; 12:7.
  76. Yonekura S, Okamoto Y, Horiguchi S, et al. Effects of aging on the natural history of seasonal allergic rhinitis in middle-aged subjects in South chiba, Japan. Int Arch Allergy Immunol 2012; 157:73.
  77. Greiner AN, Hellings PW, Rotiroti G, Scadding GK. Allergic rhinitis. Lancet 2011; 378:2112.
  78. Keil T, Bockelbrink A, Reich A, et al. The natural history of allergic rhinitis in childhood. Pediatr Allergy Immunol 2010; 21:962.
  79. Bielory L. Allergic and immunologic disorders of the eye. Part II: ocular allergy. J Allergy Clin Immunol 2000; 106:1019.
  80. Palmares J, Delgado L, Cidade M, et al. Allergic conjunctivitis: a national cross-sectional study of clinical characteristics and quality of life. Eur J Ophthalmol 2010; 20:257.
  81. Osur SL. Viral respiratory infections in association with asthma and sinusitis: a review. Ann Allergy Asthma Immunol 2002; 89:553.
  82. Rappai M, Collop N, Kemp S, deShazo R. The nose and sleep-disordered breathing: what we know and what we do not know. Chest 2003; 124:2309.
  83. Alkhalil M, Lockey R. Pediatric obstructive sleep apnea syndrome (OSAS) for the allergist: update on the assessment and management. Ann Allergy Asthma Immunol 2011; 107:104.
  84. Ku M, Silverman B, Prifti N, et al. Prevalence of migraine headaches in patients with allergic rhinitis. Ann Allergy Asthma Immunol 2006; 97:226.
  85. Czech EJ, Overholser A, Schultz P. Allergic Rhinitis. Prim Care 2023; 50:159.
  86. Seidman MD, Gurgel RK, Lin SY, et al. Clinical practice guideline: Allergic rhinitis. Otolaryngol Head Neck Surg 2015; 152:S1.
  87. Banov CH, Lieberman P, Vasomotor Rhinitis Study Groups. Efficacy of azelastine nasal spray in the treatment of vasomotor (perennial nonallergic) rhinitis. Ann Allergy Asthma Immunol 2001; 86:28.
  88. Hammersley VS, Harris J, Sheikh A, et al. Developing and testing of a screening tool to predict people without IgE-mediated allergy: a quantitative analysis of the predictive value of a screening tool. Br J Gen Pract 2017; 67:e293.
  89. Szeinbach SL, Williams PB, Kucukarslan S, Elhefni H. Influence of patient care provider on patient health outcomes in allergic rhinitis. Ann Allergy Asthma Immunol 2005; 95:167.
  90. Bousquet J, Heinzerling L, Bachert C, et al. Practical guide to skin prick tests in allergy to aeroallergens. Allergy 2012; 67:18.
  91. Cox L, Nelson H, Lockey R, et al. Allergen immunotherapy: a practice parameter third update. J Allergy Clin Immunol 2011; 127:S1.
  92. Frati F, Incorvaia C, Cavaliere C, et al. The skin prick test. J Biol Regul Homeost Agents 2018; 32:19.
  93. Duran-Tauleria E, Vignati G, Guedan MJ, Petersson CJ. The utility of specific immunoglobulin E measurements in primary care. Allergy 2004; 59 Suppl 78:35.
  94. Mansfield L, Hutteman HR, Tyson S, Enriquez A. A multiallergen and miniscreen can change primary care provider diagnosis and treatment of rhinitis. Am J Rhinol Allergy 2012; 26:218.
  95. Ahlstedt S, Murray CS. In vitro diagnosis of allergy: how to interpret IgE antibody results in clinical practice. Prim Care Respir J 2006; 15:228.
  96. Kwong KY, Eghrari-Sabet JS, Mendoza GR, et al. The benefits of specific immunoglobulin E testing in the primary care setting. Am J Manag Care 2011; 17 Suppl 17:S447.
  97. Rondón C, Eguiluz-Gracia I, Campo P. Is the evidence of local allergic rhinitis growing? Curr Opin Allergy Clin Immunol 2018; 18:342.
  98. Measurement of specific and nonspecific IgG4 levels as diagnostic and prognostic tests for clinical allergy. AAAI Board of Directors. J Allergy Clin Immunol 1995; 95:652.
  99. Harmsen L, Nolte H, Backer V. The effect of generalist and specialist care on quality of life in asthma patients with and without allergic rhinitis. Int Arch Allergy Immunol 2010; 152:288.
  100. Meltzer EO, Hamilos DL, Hadley JA, et al. Rhinosinusitis: establishing definitions for clinical research and patient care. J Allergy Clin Immunol 2004; 114:155.
  101. Settipane RA. Rhinitis: a dose of epidemiological reality. Allergy Asthma Proc 2003; 24:147.
  102. Ramey JT, Bailen E, Lockey RF. Rhinitis medicamentosa. J Investig Allergol Clin Immunol 2006; 16:148.
  103. Passàli D, Salerni L, Passàli GC, et al. Nasal decongestants in the treatment of chronic nasal obstruction: efficacy and safety of use. Expert Opin Drug Saf 2006; 5:783.
  104. Graf P. Rhinitis medicamentosa: a review of causes and treatment. Treat Respir Med 2005; 4:21.
  105. van Rijswijk JB, Blom HM, Fokkens WJ. Idiopathic rhinitis, the ongoing quest. Allergy 2005; 60:1471.
Topic 7525 Version 29.0

References

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟